In addition, CD248 is also involved in renal fibrosis (12), pulmonary fibrosis (13), arthritis (14, 15), and tumor neovascularization (16, 17), and has become a potential target for the treatment of these diseases. This evidence concerns the gene CD248 and pulmonary fibrosis.